Availability of Amiodarone Ampoules

Further to DrugAlert vol 1004, HPS Pharmacies wish to advise that Juno Pharmaceuticals is continuing to experience a supply interruption for Amiodarone Juno ampoules as follows:

Amiodarone Juno Ampoules
Amiodarone hydrochloride 150mg/3mL
ARTG 233673

This supply interruption is anticipated to continue until late June 2025.

While the Therapeutic Goods Administration (TGA) has authorised the supply of a Section 19A alternative, this product is not available due to an export ban.

An S19A approval is pending for an additional brand of amiodarone 150mg/3mL ampoules. This product is currently available for order. However, until the S19A application is approved, this product can only be accessed via the Special Access Scheme (SAS). The lead time for this product is approximately two weeks.

Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies.

Download PDF